Real World Evidence (RWE) has become vital to support and enhance market access and pricing. But what is the value of RWE, what are the shortcomings, and how can you effectively use it? Watch the recording from the Expert Insights webinar series, where Raf De Wilde, our Senior Executive Advisor is joined by an expert panel to discuss how to optimise RWE to support market access and pricing
Panelists include:
  • Jim Ballenger: Chief Pharmacy Officer for Ohio, US and Principal of BallengeRx Consulting
  • Marco Marchetti – Director for the National Center for Health Technology Assessment, Italy
  • Jindrich Kotrba – Board member at Pharmeca and former Head of Pricing and Reimbursement for the State Institute for Drug Control, Czech Republic


    By submitting this information, you agree to the Valid Insight Privacy Policy.